| Primary |
| Diabetes Mellitus |
87.9% |
| Diabetes Mellitus Insulin-dependent |
5.5% |
| Drug Use For Unknown Indication |
2.7% |
| Type 1 Diabetes Mellitus |
1.6% |
| Blood Cholesterol |
1.1% |
| Bone Density Decreased |
1.1% |
|
| Visual Acuity Reduced |
18.6% |
| Visual Disturbance |
8.5% |
| Loss Of Consciousness |
6.8% |
| Myocardial Infarction |
6.8% |
| Weight Increased |
6.8% |
| Pharmaceutical Product Complaint |
5.1% |
| Blood Glucose Increased |
3.4% |
| Dehydration |
3.4% |
| Diabetic Ketoacidosis |
3.4% |
| Drug Exposure During Pregnancy |
3.4% |
| Hypersensitivity |
3.4% |
| Malaise |
3.4% |
| Nephrolithiasis |
3.4% |
| Pancreatic Disorder |
3.4% |
| Prostate Cancer |
3.4% |
| Renal Disorder |
3.4% |
| Renal Failure Chronic |
3.4% |
| Stomach Discomfort |
3.4% |
| Urticaria |
3.4% |
| Wound Infection Staphylococcal |
3.4% |
|
| Secondary |
| Diabetes Mellitus |
81.9% |
| Diabetes Mellitus Insulin-dependent |
9.2% |
| Type 2 Diabetes Mellitus |
2.5% |
| Type 1 Diabetes Mellitus |
2.1% |
| Blood Cholesterol |
1.7% |
| Blood Pressure |
1.7% |
| Drug Use For Unknown Indication |
0.4% |
| Hypertension |
0.4% |
|
| Visual Acuity Reduced |
22.0% |
| Pharmaceutical Product Complaint |
8.5% |
| Weight Decreased |
8.5% |
| Wound Infection Staphylococcal |
6.8% |
| Loss Of Consciousness |
5.1% |
| Viral Infection |
5.1% |
| Vomiting |
5.1% |
| Anaphylactic Shock |
3.4% |
| Blood Glucose Increased |
3.4% |
| Hypoglycaemia |
3.4% |
| Mouth Injury |
3.4% |
| Renal Transplant |
3.4% |
| Road Traffic Accident |
3.4% |
| Speech Disorder |
3.4% |
| Spinal Fusion Surgery |
3.4% |
| Vitamin D Decreased |
3.4% |
| Wrong Drug Administered |
3.4% |
| Anti-insulin Antibody Positive |
1.7% |
| Blindness |
1.7% |
| Blood Glucose Decreased |
1.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
41.2% |
| Product Used For Unknown Indication |
11.8% |
| Renal Failure Chronic |
8.8% |
| Diabetes Mellitus Non-insulin-dependent |
4.4% |
| Pulmonary Arterial Hypertension |
4.4% |
| Diabetes Mellitus |
2.9% |
| Hypertension |
2.9% |
| Multiple Myeloma |
2.9% |
| Skin Wrinkling |
2.9% |
| Vasculitis |
2.9% |
| Antibiotic Prophylaxis |
1.5% |
| Cardiovascular Disorder |
1.5% |
| Crohn's Disease |
1.5% |
| Hypercholesterolaemia |
1.5% |
| Hypertriglyceridaemia |
1.5% |
| Infection |
1.5% |
| Klebsiella Infection |
1.5% |
| Microscopic Polyangiitis |
1.5% |
| Off Label Use |
1.5% |
| Type 1 Diabetes Mellitus |
1.5% |
|
| Therapeutic Response Decreased |
18.5% |
| Headache |
11.1% |
| Drug Ineffective |
7.4% |
| Nausea |
7.4% |
| Vision Blurred |
7.4% |
| Arthralgia |
3.7% |
| Death |
3.7% |
| Flushing |
3.7% |
| Head Injury |
3.7% |
| Paraesthesia |
3.7% |
| Plasma Cell Myeloma |
3.7% |
| Platelet Count Decreased |
3.7% |
| Pruritus |
3.7% |
| Renal Failure Acute |
3.7% |
| Somnolence |
3.7% |
| Thrombotic Microangiopathy |
3.7% |
| Urinary Tract Infection |
3.7% |
| Vertigo |
3.7% |
|
